The novel approach of this peptide represents a major development in the handling of the condition. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide619558.mdkblog.com/48182642/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment